Skip to main content
Clinical Trials/NCT01208987
NCT01208987
Completed
Not Applicable

Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices

Indiana University1 site in 1 country5,256 target enrollmentSeptember 28, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Medication Histories in Outpatient Clinic Patients
Sponsor
Indiana University
Enrollment
5256
Locations
1
Primary Endpoint
Count of medications (on a patient's medication list) for which recent (within 12 months) laboratory test monitoring is missing.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The investigators plan to develop a process to create an Enhanced Medication List. The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard Health Services. The investigators will collect all the medication data available through the INPC for an individual patient. The investigators will enhance this medication list by including medication categories, improving the structure and appearance, displaying results of relevant laboratory tests, and adding decision support reminders. The investigators will test the value of such an "Enhanced Medication List" by providing it to outpatient physician practices (through the DOCS4DOCS clinical messaging service, or as a fax), preferably on the day that the patient has an office visit with the physician. The investigators will determine whether this intervention improves patient care: whether there are higher rates of recommended laboratory follow-up monitoring as a result; whether there are lower rates of harmful drug-drug interactions. The investigators will also seek the opinions of physicians regarding the benefit of this intervention.

Registry
clinicaltrials.gov
Start Date
September 28, 2007
End Date
October 1, 2011
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • outpatient clinic patient visits

Exclusion Criteria

  • Age 18 and under

Outcomes

Primary Outcomes

Count of medications (on a patient's medication list) for which recent (within 12 months) laboratory test monitoring is missing.

Time Frame: Laboratory tests during the previous 12 months

The hypothesis is that the intervention (a medication history printed for the patient) would help the physician identify incomplete monitoring of laboratory test results for a subset of medications. (For example, Potassium test levels should be obtained every 12 months for patients using diuretics, according to NCQA HEDIS guidelines.) With time, the intervention group should have less medications for which laboratory test results are incomplete. Therefore, the intervention group should have less medications with decision support reminders warning of incomplete laboratory test monitoring.

Study Sites (1)

Loading locations...

Similar Trials